BioCardia, Inc. Warrant
BCDAW
BCDAW was delisted on the 2nd of August, 2024.
3 hedge funds and large institutions have $879K invested in BioCardia, Inc. Warrant in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.
153% more capital invested
Capital invested by funds: $348K → $879K (+$531K)
50% more funds holding
Funds holding: 2 → 3 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$13K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $770K | – | – | – |
|
2
Osaic Holdings
Scottsdale,
Arizona
| $95K | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $14K | +$13K | +10,513 | New |
|
BCDAW Hedge Fund Activity: Q4 2020 in Review
3 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q4 2020, worth a combined $879K — up 153% from $348K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BCDAW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $13K.
- 3 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q4 2020, up from 2 in Q3 2020.
- Funds reported $879K of BioCardia, Inc. Warrant stock for Q4 2020, up 153% quarter-over-quarter.
- 1 fund opened new BioCardia, Inc. Warrant positions in Q4 2020 and 0 closed out, a net change of +1 holder.
- The largest BioCardia, Inc. Warrant buyer in Q4 2020 was Susquehanna International Group, an estimated $13K added.
Based on aggregated 13F filings for Q4 2020.